| Entry |
|
|---|
| Symbol |
VEGFA
|
|---|
| Name |
(RefSeq) vascular endothelial growth factor A
|
|---|
| KO |
| K05448 | vascular endothelial growth factor A |
|
|---|
| Organism |
csab Chlorocebus sabaeus (green monkey)
|
|---|
| Pathway |
| csab01521 | EGFR tyrosine kinase inhibitor resistance |
| csab04933 | AGE-RAGE signaling pathway in diabetic complications |
| csab05167 | Kaposi sarcoma-associated herpesvirus infection |
| csab05207 | Chemical carcinogenesis - receptor activation |
| csab05208 | Chemical carcinogenesis - reactive oxygen species |
| csab05418 | Fluid shear stress and atherosclerosis |
|
|---|
| Brite |
KEGG Orthology (KO) [BR:csab00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103221446 (VEGFA)
04014 Ras signaling pathway
103221446 (VEGFA)
04015 Rap1 signaling pathway
103221446 (VEGFA)
04370 VEGF signaling pathway
103221446 (VEGFA)
04066 HIF-1 signaling pathway
103221446 (VEGFA)
04020 Calcium signaling pathway
103221446 (VEGFA)
04151 PI3K-Akt signaling pathway
103221446 (VEGFA)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04510 Focal adhesion
103221446 (VEGFA)
09150 Organismal Systems
09152 Endocrine system
04926 Relaxin signaling pathway
103221446 (VEGFA)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103221446 (VEGFA)
05206 MicroRNAs in cancer
103221446 (VEGFA)
05205 Proteoglycans in cancer
103221446 (VEGFA)
05207 Chemical carcinogenesis - receptor activation
103221446 (VEGFA)
05208 Chemical carcinogenesis - reactive oxygen species
103221446 (VEGFA)
09162 Cancer: specific types
05212 Pancreatic cancer
103221446 (VEGFA)
05211 Renal cell carcinoma
103221446 (VEGFA)
05219 Bladder cancer
103221446 (VEGFA)
09172 Infectious disease: viral
05163 Human cytomegalovirus infection
103221446 (VEGFA)
05167 Kaposi sarcoma-associated herpesvirus infection
103221446 (VEGFA)
05165 Human papillomavirus infection
103221446 (VEGFA)
09163 Immune disease
05323 Rheumatoid arthritis
103221446 (VEGFA)
09166 Cardiovascular disease
05418 Fluid shear stress and atherosclerosis
103221446 (VEGFA)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
103221446 (VEGFA)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
103221446 (VEGFA)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:csab04052]
103221446 (VEGFA)
00536 Glycosaminoglycan binding proteins [BR:csab00536]
103221446 (VEGFA)
Cytokines and neuropeptides [BR:csab04052]
Cytokines
Growth factors (RTK binding)
103221446 (VEGFA)
Glycosaminoglycan binding proteins [BR:csab00536]
Heparan sulfate / Heparin
Growth factors/receptors
103221446 (VEGFA)
|
|---|
| SSDB |
|
|---|
| Motif |
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| Position |
17:complement(28377959..28394508)
|
|---|
| AA seq |
215 aa
MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVD
IFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEM
SFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVPCGPCSERRKHLFVQ
DPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR |
|---|
| NT seq |
648 nt +upstreamnt +downstreamnt
atgaactttctgctctcttgggtgcattggagccttgccttgctgctgtacctccaccat
gccaagtggtcccaggctgcacccatggcagaaggaggagggcagaatcatcacgaagtg
gtaaagttcatggatgtctatcagcgcagctactgccatccaatcgagaccctggtggac
atcttccaggagtaccctgatgagattgagtacatcttcaagccgtcctgtgtgcccctg
atgcgatgtgggggctgctgcaatgacgagggcctggagtgtgtgcccactgaggagtcc
aacatcaccatgcagattatgcggatcaaacctcaccaaggccagcacataggagagatg
agcttcctacagcacaacaaatgtgaatgcagaccaaagaaagatagagcaagacaagaa
aaaaaatcagttcgaggaaagggaaaggggcaaaaacgaaagcgcaagaaatcccggtat
aagtcctggagcgttccctgtgggccttgctcagagcggagaaagcatttgtttgtacaa
gatccgcagacgtgtaaatgttcctgcaaaaacacagactcgcgttgcaaggcgaggcag
cttgagttaaacgaacgtacttgcagatgtgacaagccgaggcggtga |
|---|
